Annals of Surgical Oncology

, Volume 16, Issue 12, pp 3219–3226

Outcome of Low-Volume Surgery for Esophageal Cancer in a High-Volume Referral Center

  • Ewout F. W. Courrech Staal
  • Frits van Coevorden
  • Annemieke Cats
  • Berthe M. P. Aleman
  • Marie-Louise F. van Velthuysen
  • Henk Boot
  • Marie-Jeanne T. F. D. Vrancken Peeters
  • Johanna W. van Sandick
Healthcare Policy and Outcomes



There is a known inverse relationship between the number of esophagectomies and in-hospital mortality. Our institute is a tertiary referral center with a high caseload of esophageal cancer patients, but with a low annual volume of esophagectomies. The objective of our study was to evaluate the results of esophageal cancer surgery in our institute and to compare these results with published data from high-surgical-volume institutions.


Between 1995 and 2007, 1,499 patients with esophageal cancer were referred: for a second opinion only (n = 568), following earlier treatment (n = 103), for palliative treatment (n = 665) or for potentially curative treatment (local endoscopic therapy n = 5, definitive chemoradiotherapy n = 71, or surgery n = 87). The surgically treated patients were studied in detail, and compared with patients treated in high-surgical-volume hospitals.


Surgery consisted of a transhiatal (n = 71) or transthoracic (n = 12) esophagectomy, or exploration only (n = 4). Fifty-six (64%) patients received neoadjuvant treatment. A microscopic radical resection was achieved in 96%. Pathologic complete response rate was 25%. Forty-four (53%) patients had a complicated postoperative course, and one (1%) patient died. At a median postoperative follow-up of 30 (1–149) months, 1- and 3-year overall survival rates were 89% and 60%, respectively. No major differences were observed between our results and those presented in six large study cohorts with high operative volumes.


Outcome of low-volume esophageal surgery can be comparable to published high-surgical-volume results. More relevant factors other than hospital volume alone should be taken into account to improve outcome of esophageal cancer surgery.


  1. 1.
    Hulscher JB, Tijssen JG, Obertop H, van Lanschot JJ. Transthoracic versus transhiatal resection for carcinoma of the esophagus: a meta-analysis. Ann Thorac Surg. 2001;72:306–13.CrossRefPubMedGoogle Scholar
  2. 2.
    Parkin DM, Bray FI, Devesa SS. Cancer burden in the year 2000. The global picture. Eur J Cancer. 2001;37(Suppl 8):S4–66.CrossRefPubMedGoogle Scholar
  3. 3.
    Visser OCJ, Schouten LJ, van Dijk JAAM. Incidence of cancer in the Netherlands 1997. Vereniging van Integrale Kankercentra: Utrecht; 2001.Google Scholar
  4. 4.
    Gebski V, Burmeister B, Smithers BM, Foo K, Zalcberg J, Simes J. Survival benefits from neoadjuvant chemoradiotherapy or chemotherapy in oesophageal carcinoma: a meta-analysis. Lancet Oncol. 2007;8:226–34.CrossRefPubMedGoogle Scholar
  5. 5.
    Birkmeyer JD, Stukel TA, Siewers AE, Goodney PP, Wennberg DE, Lucas FL. Surgeon volume and operative mortality in the United States. N Engl J Med. 2003;349:2117–27.CrossRefPubMedGoogle Scholar
  6. 6.
    Killeen SD, O’Sullivan MJ, Coffey JC, Kirwan WO, Redmond HP. Provider volume and outcomes for oncological procedures. Br J Surg. 2005;92:389–402.CrossRefPubMedGoogle Scholar
  7. 7.
    Chowdhury MM, Dagash H, Pierro A. A systematic review of the impact of volume of surgery and specialization on patient outcome. Br J Surg. 2007;94:145–61.CrossRefPubMedGoogle Scholar
  8. 8.
    Forastiere AA, Orringer MB, Perez-Tamayo C, Urba SG, Zahurak M. Preoperative chemoradiation followed by transhiatal esophagectomy for carcinoma of the esophagus: final report. J Clin Oncol. 1993;11:1118–23.PubMedGoogle Scholar
  9. 9.
    Walsh TN, Noonan N, Hollywood D, Kelly A, Keeling N, Hennessy TP. A comparison of multimodal therapy and surgery for esophageal adenocarcinoma. N Engl J Med. 1996;335:462–7.CrossRefPubMedGoogle Scholar
  10. 10.
    Al Sarraf M, Martz K, Herskovic A, et al. Progress report of combined chemoradiotherapy versus radiotherapy alone in patients with esophageal cancer: an intergroup study. J Clin Oncol. 1997;15:277–84.PubMedGoogle Scholar
  11. 11.
    Polee MB, Sparreboom A, Eskens FA, et al. A phase I and pharmacokinetic study of weekly paclitaxel and carboplatin in patients with metastatic esophageal cancer. Clin Cancer Res. 2004;10:1928–34.CrossRefPubMedGoogle Scholar
  12. 12.
    El Rayes BF, Shields A, Zalupski M, et al. A phase II study of carboplatin and paclitaxel in esophageal cancer. Ann Oncol 2004;15:960–5.CrossRefPubMedGoogle Scholar
  13. 13.
    Wang H, Ryu J, Gandara D, et al. A phase II study of paclitaxel, carboplatin, and radiation with or without surgery for esophageal cancer. J Thorac Oncol. 2007;2:153–7.CrossRefPubMedGoogle Scholar
  14. 14.
    Bamias A, Hill ME, Cunningham D, et al. Epirubicin, cisplatin, and protracted venous infusion of 5-fluorouracil for esophagogastric adenocarcinoma: response, toxicity, quality of life, and survival. Cancer. 1996;77:1978–85.CrossRefPubMedGoogle Scholar
  15. 15.
    Evans TR, Pentheroudakis G, Paul J, et al. A phase I and pharmacokinetic study of capecitabine in combination with epirubicin and cisplatin in patients with inoperable oesophago-gastric adenocarcinoma. Ann Oncol. 2002;13:1469–78.CrossRefPubMedGoogle Scholar
  16. 16.
    Sobin LH, Wittekind C. TNM classification of malignant tumours, 6th ed. New York: Wiley-Liss; 2002.Google Scholar
  17. 17.
    Orringer MB, Marshall B, Chang AC, Lee J, Pickens A, Lau CL. Two thousand transhiatal esophagectomies: changing trends, lessons learned. Ann Surg. 2007;246:363–72.CrossRefPubMedGoogle Scholar
  18. 18.
    Lagarde SM, de Boer JD, Ten Kate FJ, Busch OR, Obertop H, van Lanschot JJ. Postoperative complications after esophagectomy for adenocarcinoma of the esophagus are related to timing of death due to recurrence. Ann Surg. 2008;247:71–6.CrossRefPubMedGoogle Scholar
  19. 19.
    Wouters MW, Wijnhoven BP, Karim-Kos HE, et al. High-volume versus low-volume for esophageal resections for cancer: the essential role of case-mix adjustments based on clinical data. Ann Surg Oncol. 2008;15:80–7.CrossRefPubMedGoogle Scholar
  20. 20.
    Davies AR, Forshaw MJ, Khan AA, Noorani AS, Patel VM, Strauss DC, et al. Transhiatal esophagectomy in a high volume institution. World J Surg Oncol. 2008;6:88.CrossRefPubMedGoogle Scholar
  21. 21.
    Rutegard M, Lagergren J, Rouvelas I, Lagergren P. Surgeon volume is a poor proxy for skill in esophageal cancer surgery. Ann Surg. 2009;249:256–61.CrossRefPubMedGoogle Scholar
  22. 22.
    Ruol A, Castoro C, Portale G, et al. Trends in management and prognosis for esophageal cancer surgery: twenty-five years of experience at a single institution. Arch Surg. 2009;144:247–54.CrossRefPubMedGoogle Scholar
  23. 23.
    Lagarde SM, Reitsma JB, Maris AK, et al. Preoperative prediction of the occurrence and severity of complications after esophagectomy for cancer with use of a nomogram. Ann Thorac Surg. 2008;85:1938–45.CrossRefPubMedGoogle Scholar
  24. 24.
    Enzinger PC, Mayer RJ. Esophageal cancer. N Engl J Med. 2003;349:2241–52.CrossRefPubMedGoogle Scholar
  25. 25.
    Urba SG, Orringer MB, Turrisi A, Iannettoni M, Forastiere A, Strawderman M. Randomized trial of preoperative chemoradiation versus surgery alone in patients with locoregional esophageal carcinoma. J Clin Oncol. 2001;19:305–13.PubMedGoogle Scholar
  26. 26.
    Nieveen van Dijkum EJ, de Wit LT, van Delden OM, Rauws EA, van Lanschot JJ, Obertop H, et al. The efficacy of laparoscopic staging in patients with upper gastrointestinal tumors. Cancer. 1997;79:1315–9.CrossRefPubMedGoogle Scholar
  27. 27.
    van Lanschot JJ, Hulscher JB, Buskens CJ, Tilanus HW, Ten Kate FJ, Obertop H. Hospital volume and hospital mortality for esophagectomy. Cancer. 2001;91:1574–8.CrossRefPubMedGoogle Scholar
  28. 28.
    Rodgers M, Jobe BA, O’Rourke RW, Sheppard B, Diggs B, Hunter JG. Case volume as a predictor of inpatient mortality after esophagectomy. Arch Surg. 2007;142:829–39.CrossRefPubMedGoogle Scholar
  29. 29.
    Urbach DR, Baxter NN. Does it matter what a hospital is “high volume” for? Specificity of hospital volume-outcome associations for surgical procedures: analysis of administrative data. BMJ. 2004;328:737–40.CrossRefPubMedGoogle Scholar

Copyright information

© Society of Surgical Oncology 2009

Authors and Affiliations

  • Ewout F. W. Courrech Staal
    • 1
  • Frits van Coevorden
    • 1
  • Annemieke Cats
    • 2
  • Berthe M. P. Aleman
    • 3
  • Marie-Louise F. van Velthuysen
    • 4
  • Henk Boot
    • 2
  • Marie-Jeanne T. F. D. Vrancken Peeters
    • 1
  • Johanna W. van Sandick
    • 1
  1. 1.Department of Surgical OncologyThe Netherlands Cancer Institute-Antoni van Leeuwenhoek HospitalAmsterdamThe Netherlands
  2. 2.Department of Gastroenterology and HepatologyThe Netherlands Cancer Institute-Antoni van Leeuwenhoek HospitalAmsterdamThe Netherlands
  3. 3.Department of RadiotherapyThe Netherlands Cancer Institute-Antoni van Leeuwenhoek HospitalAmsterdamThe Netherlands
  4. 4.Department of PathologyThe Netherlands Cancer Institute-Antoni van Leeuwenhoek HospitalAmsterdamThe Netherlands

Personalised recommendations